-
1دورية أكاديمية
المؤلفون: Robinson P; Department of Infectious Diseases, Infection Control & Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA., Montoya K; Department of Infectious Diseases, Infection Control & Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA., Magness E; Department of Infectious Diseases, Infection Control & Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA., Rodriguez E; Department of Infectious Diseases, Infection Control & Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA., Villalobos V; Department of Infectious Diseases, Infection Control & Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA., Engineer N; Department of Infectious Diseases, Infection Control & Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA., Yang P; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA., Bharadwaj U; Department of Infectious Diseases, Infection Control & Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA., Eckols TK; Department of Infectious Diseases, Infection Control & Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA., Tweardy DJ; Department of Infectious Diseases, Infection Control & Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA.; Department of Molecular & Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA.
المصدر: Cancers [Cancers (Basel)] 2023 May 30; Vol. 15 (11). Date of Electronic Publication: 2023 May 30.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
-
2دورية أكاديمية
المؤلفون: Robinson P; Departments of Infectious Diseases, Infection Control & Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-3772, USA., Magness E; Departments of Infectious Diseases, Infection Control & Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-3772, USA., Montoya K; Departments of Infectious Diseases, Infection Control & Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-3772, USA., Engineer N; Departments of Infectious Diseases, Infection Control & Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-3772, USA., Eckols TK; Departments of Infectious Diseases, Infection Control & Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-3772, USA., Rodriguez E; Departments of Infectious Diseases, Infection Control & Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-3772, USA., Tweardy DJ; Departments of Infectious Diseases, Infection Control & Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-3772, USA.; Molecular & Cellular Oncology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-3772, USA.
المصدر: Journal of clinical medicine [J Clin Med] 2022 Nov 28; Vol. 11 (23). Date of Electronic Publication: 2022 Nov 28.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE
-
3دورية أكاديمية
المؤلفون: Kong R; Department of Systems Medicine and Bioengineering, Houston Methodist Cancer Center, Weill Cornell Medicine, Houston, TX, 77030, USA; Institute of Bioinformatics and Medical Engineering, School of Electrical and Information Engineering, Jiangsu University of Technology, Changzhou, Jiangsu, 213001, PR China., Bharadwaj U; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Eckols TK; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kolosov M; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wu H; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cruz-Pavlovich FJS; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shaw A; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ifelayo OI; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhao H; Department of Systems Medicine and Bioengineering, Houston Methodist Cancer Center, Weill Cornell Medicine, Houston, TX, 77030, USA., Kasembeli MM; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wong STC; Department of Systems Medicine and Bioengineering, Houston Methodist Cancer Center, Weill Cornell Medicine, Houston, TX, 77030, USA. Electronic address: stwong@houstonmethodist.org., Tweardy DJ; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: djtweardy@mdanderson.org.
المصدر: Pharmacological research [Pharmacol Res] 2021 Jul; Vol. 169, pp. 105637. Date of Electronic Publication: 2021 Apr 29.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8907422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-1186 (Electronic) Linking ISSN: 10436618 NLM ISO Abbreviation: Pharmacol Res Subsets: MEDLINE
مواضيع طبية MeSH: src Homology Domains*/drug effects, Drug Evaluation, Preclinical/*methods , STAT3 Transcription Factor/*antagonists & inhibitors, Alkylation ; Binding Sites/drug effects ; Blotting, Western ; Cell Line, Tumor/drug effects ; Gas Chromatography-Mass Spectrometry ; Humans ; Ligands ; Molecular Docking Simulation ; Protein Structure, Tertiary ; STAT3 Transcription Factor/chemistry ; STAT3 Transcription Factor/genetics ; Structure-Activity Relationship ; Surface Plasmon Resonance
-
4دورية أكاديمية
المؤلفون: Legi A; Division of Internal Medicine, Department of Infectious Diseases, Infection Control & Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-3772, USA., Rodriguez E; Division of Internal Medicine, Department of Infectious Diseases, Infection Control & Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-3772, USA., Eckols TK; Division of Internal Medicine, Department of Infectious Diseases, Infection Control & Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-3772, USA., Mistry C; University of Texas at Dallas, Richardson, TX 75080, USA., Robinson P; Division of Internal Medicine, Department of Infectious Diseases, Infection Control & Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-3772, USA.
المصدر: Cancers [Cancers (Basel)] 2021 Apr 06; Vol. 13 (7). Date of Electronic Publication: 2021 Apr 06.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
-
5دورية أكاديمية
المؤلفون: Zhang L; Nephrology Division, Department of Medicine, Baylor College of Medicine, Houston, Texas., Wang Y; Nephrology Division, Department of Medicine, Baylor College of Medicine, Houston, Texas., Dong Y; Nephrology Division, Department of Medicine, Baylor College of Medicine, Houston, Texas., Chen Z; Nephrology Division, Department of Medicine, Baylor College of Medicine, Houston, Texas., Eckols TK; Division of Internal Medicine, Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kasembeli MM; Division of Internal Medicine, Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tweardy DJ; Division of Internal Medicine, Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Mitch WE; Nephrology Division, Department of Medicine, Baylor College of Medicine, Houston, Texas.
المصدر: American journal of physiology. Renal physiology [Am J Physiol Renal Physiol] 2020 Jul 01; Vol. 319 (1), pp. F84-F92. Date of Electronic Publication: 2020 Jun 01.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901990 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-1466 (Electronic) Linking ISSN: 15221466 NLM ISO Abbreviation: Am J Physiol Renal Physiol Subsets: MEDLINE
مواضيع طبية MeSH: Enzyme Inhibitors/*pharmacology , Muscle, Skeletal/*drug effects , Naphthols/*pharmacology , Proteolysis/*drug effects , Renal Insufficiency, Chronic/*metabolism , STAT3 Transcription Factor/*antagonists & inhibitors , Sulfonamides/*pharmacology, Animals ; Body Weight/drug effects ; Chromatography, Liquid ; Disease Models, Animal ; Enzyme Inhibitors/pharmacokinetics ; Hand Strength ; Muscle, Skeletal/metabolism ; Naphthols/pharmacokinetics ; Rats ; Sulfonamides/pharmacokinetics ; Tandem Mass Spectrometry
-
6دورية أكاديمية
المؤلفون: Kettner NM; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. kkeyomar@mdanderson.org NMKettner@mdanderson.org., Vijayaraghavan S; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Durak MG; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bui T; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kohansal M; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ha MJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Liu B; Department of Human Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Rao X; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yi M; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Carey JPW; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chen X; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Eckols TK; Department of Infectious Diseases, Infection Control & Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Raghavendra AS; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ibrahim NK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Karuturi MS; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Watowich SS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sahin A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tweardy DJ; Department of Infectious Diseases, Infection Control & Employee Health, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Molecular & Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hunt KK; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tripathy D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Keyomarsi K; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. kkeyomar@mdanderson.org NMKettner@mdanderson.org.
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Jul 01; Vol. 25 (13), pp. 3996-4013. Date of Electronic Publication: 2019 Mar 13.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Drug Resistance, Neoplasm*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Breast Neoplasms/*drug therapy , Breast Neoplasms/*metabolism , DNA Repair/*drug effects , Receptors, Estrogen/*metabolism , STAT3 Transcription Factor/*antagonists & inhibitors, Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Breast Neoplasms/pathology ; Cell Line, Tumor ; Computational Biology/methods ; Epithelial-Mesenchymal Transition/genetics ; Female ; Gene Expression Profiling ; Humans ; Immunohistochemistry ; Piperazines/pharmacology ; Piperazines/therapeutic use ; Protein Kinase Inhibitors/pharmacology ; Pyridines/pharmacology ; Pyridines/therapeutic use ; Treatment Outcome
-
7دورية أكاديمية
المؤلفون: Bharadwaj U; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Eckols TK; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Xu X; The Key Laboratory of Natural Medicine and Immuno-Engineering, Henan University, Kaifeng, China., Kasembeli MM; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chen Y; Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Adachi M; Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Song Y; Department of Pharmacology, Baylor College of Medicine, Houston, Texas, USA., Mo Q; Department of Medicine, Division of Biostatistics, Dan L. Duncan Cancer Center, Section of Hematology/Oncology, Baylor College of Medicine, Houston, Texas, USA., Lai SY; Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tweardy DJ; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Molecular & Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
المصدر: Oncotarget [Oncotarget] 2019 Feb 22; Vol. 10 (16), pp. 1603. Date of Electronic Publication: 2019 Feb 22 (Print Publication: 2019).
نوع المنشور: Journal Article; Published Erratum
بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
-
8دورية أكاديمية
المؤلفون: Jung KH; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yoo W; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Stevenson HL; Department of Pathology, University of Texas Medical Branch, Galveston, Texas., Deshpande D; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Shen H; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gagea M; Department of Veterinary Medicine & Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas., Yoo SY; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Eckols TK; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bharadwaj U; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tweardy DJ; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas., Beretta L; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. lberetta@mdanderson.org.
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Sep 15; Vol. 23 (18), pp. 5537-5546. Date of Electronic Publication: 2017 May 22.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Carcinoma, Hepatocellular/*metabolism , Liver Neoplasms/*metabolism , Naphthols/*pharmacology , Non-alcoholic Fatty Liver Disease/*metabolism , STAT3 Transcription Factor/*antagonists & inhibitors , Sulfonamides/*pharmacology, Animals ; Antineoplastic Agents/pharmacology ; Biopsy ; Carcinoma, Hepatocellular/diagnosis ; Carcinoma, Hepatocellular/drug therapy ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Cytokines/metabolism ; Disease Models, Animal ; Gene Expression Profiling ; Humans ; Immunohistochemistry ; Inflammation Mediators ; Liver Function Tests ; Liver Neoplasms/drug therapy ; Liver Neoplasms/pathology ; Magnetic Resonance Imaging ; Mice ; Mice, Knockout ; Non-alcoholic Fatty Liver Disease/diagnosis ; Non-alcoholic Fatty Liver Disease/drug therapy ; PTEN Phosphohydrolase/genetics ; PTEN Phosphohydrolase/metabolism ; Signal Transduction/drug effects ; Xenograft Model Antitumor Assays
-
9دورية أكاديمية
المؤلفون: Bharadwaj U; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Eckols TK; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Xu X; The Key Laboratory of Natural Medicine and Immuno-Engineering, Henan University, Kaifeng, China., Kasembeli MM; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chen Y; Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Adachi M; Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Song Y; Department of Pharmacology, Baylor College of Medicine, Houston, Texas, USA., Mo Q; Department of Medicine, Division of Biostatistics, Dan L. Duncan Cancer Center, Section of Hematology/Oncology, Baylor College of Medicine, Houston, Texas, USA., Lai SY; Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tweardy DJ; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Molecular & Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
المصدر: Oncotarget [Oncotarget] 2016 May 03; Vol. 7 (18), pp. 26307-30.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Agents/*pharmacology , Carcinoma, Squamous Cell/*drug therapy , Head and Neck Neoplasms/*drug therapy , Naphthols/*pharmacology , STAT3 Transcription Factor/*antagonists & inhibitors , Sulfonamides/*pharmacology, Animals ; Antineoplastic Agents/chemical synthesis ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Drug Screening Assays, Antitumor ; Humans ; Mice ; Mice, Nude ; Naphthols/chemical synthesis ; Radiation Tolerance/drug effects ; Squamous Cell Carcinoma of Head and Neck ; Sulfonamides/chemical synthesis ; Xenograft Model Antitumor Assays
-
10دورية أكاديمية
المؤلفون: Lewis KM; Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Bharadwaj U; Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Eckols TK; Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Kolosov M; Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Kasembeli MM; Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Fridley C; Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA., Siller R; Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Tweardy DJ; Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, USA. Electronic address: DJTweardy@mdanderson.org.
المصدر: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2015 Nov; Vol. 90 (2), pp. 182-90. Date of Electronic Publication: 2015 Sep 15.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Agents/*pharmacology , Carcinoma, Non-Small-Cell Lung/*drug therapy , Lung Neoplasms/*drug therapy , STAT3 Transcription Factor/*genetics , Signal Transduction/*drug effects , Transcriptional Activation/*drug effects, Animals ; Apoptosis/drug effects ; Apoptosis/genetics ; Carcinoma, Non-Small-Cell Lung/genetics ; Cell Line ; Cell Line, Tumor ; Cell Survival/drug effects ; Cell Survival/genetics ; Gene Expression Regulation, Neoplastic/drug effects ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Lung/drug effects ; Lung Neoplasms/genetics ; Mice ; Mice, Nude ; Phosphorylation/drug effects ; Phosphorylation/genetics ; RNA, Small Interfering/genetics ; Signal Transduction/genetics ; Transcriptional Activation/genetics